Co-Prescribing to Reduce Overdoses Act of 2016

Bill: 114-hr-3680
Sponsor: Rep. Sarbanes, John P. [D-MD-3]
Introduced: 2015-10-01 in the House
Policy area: Health
Subjects: Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health programs administration and funding
Prescription drugs
State and local government operations

Summary:
action_date: 2015-10-01
text: 

Co-Prescribing to Reduce Overdoses Act of 2015

 
This bill requires the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
 
Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists on prescription of such drugs, track patients and outcomes, and for other specified activities.
 HHS must award grants to certain community groups and state and municipal health departments to develop guidelines on prescribing opioid overdose reversal drugs.
action_date: 2016-05-10
text: 

Co-Prescribing to Reduce Overdoses Act of 2016

 
(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
 
Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.
 
(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.
 
(Sec. 4) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.

action_date: 2016-05-11
text: 

Co-Prescribing to Reduce Overdoses Act of 2016

 
(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
 
Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.
 
(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.
 
(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.


Legislative actions:
action_date: 2016-05-12
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2016-05-11
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2016-05-11
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2256-2257)
action_date: 2016-05-11
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2256-2257)
action_date: 2016-05-11
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 3680.
action_date: 2016-05-11
text: Considered under suspension of the rules. (consideration: CR H2256-2259)
action_date: 2016-05-11
text: Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
action_date: 2016-05-10
text: Placed on the Union Calendar, Calendar No. 427.
action_date: 2016-05-10
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-553.
action_date: 2016-05-10
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-553.
action_date: 2016-04-28
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2016-04-28
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-27
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-26
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-25
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-20
text: Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
action_date: 2016-04-20
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2015-10-02
text: Referred to the Subcommittee on Health.
action_date: 2015-10-01
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-10-01
text: Introduced in House
action_date: 2015-10-01
text: Introduced in House